... 脱羧酶类 dekarboksylaza 纤溶酶原激活物 aktywator plazminogenu 纤维胶 wiskoza ...
基于4个网页-相关网页
组织纤溶酶原激活物 PLAT ; tissue plasminogen activator ; tissue-type plasminogen activator
组织型纤溶酶原激活物 tissue plasminogen activator ; t-PA ; tissue-type plasminogen activator ; T PA
纤溶酶原激活物抑制物 PAI ; plasminogen activator inhibitor ; type 1 plasminogen activator inhibitor
尿激酶纤溶酶原激活物 urokinase-type plasminogen activator ; urokinase plasminogen activator
尿纤溶酶原激活物 Urinary plasminogen activator
纤溶酶原激活物受体 plasminogen activator receptor
纤溶酶原激活物抑制剂 plasminogen activator inhibitor
尿纤溶酶原激活物受体 urokinase-type plasminogen active receptor
纤溶酶原激活抑制物 plasminogen activator inhibitor
Objective:To examine whether pravastatin can inhibit the secretion of plasminogen activator inhibitor type 1 ( PAI 1 ).
目的 :研究普伐他汀 (pravastatin)是否能抑制肝细胞分泌纤溶酶原激活物抑制物 - 1(PAI- 1)。
参考来源 - 普伐他汀对HepG·2,447,543篇论文数据，部分数据来源于NoteExpress
血浆纤溶酶原激活物抑制剂(PAI) - 1是纤溶系统的主要调控因子。
Plasminogen activator inhibitor-1 (PAI-1) is the main regulator of the fibrinolytic system.
目的探讨纤溶酶原激活物抑制物- 1（ PAI- 1）启动子区基因多态性与脑卒中的关系。
Objective To investigate the relationship between the plasminogen activator inhibitor 1(PAI 1) promotor region gene polymorphism and cerebral stroke.
用酶联免疫吸附法检测血浆血管性假性血友病因子、凝血酶调节蛋白、纤溶酶原激活物抑制物1水平。
The von Willebrand's disease factors in plasm, adjusted protein of thrombase and inhibitor 1 of activator of plasminogen were detected with enzyme-linked immunosorbent assay.
应用推荐